Literature DB >> 15492975

Rationale for growth hormone therapy in children with chronic kidney disease.

Larry A Greenbaum1, Marcela Del Rio, Fatai Bamgbola, Frederick Kaskel.   

Abstract

Growth retardation is a common complication in children with chronic kidney disease. Treatable causes of growth retardation in these patients include renal osteodystrophy, metabolic acidosis, and inadequate nutritional intake. In addition, disturbances in the growth hormone-insulinlike growth factor I axis are a major cause of decreased growth. Administration of recombinant human growth hormone can overcome this problem, allowing catch-up growth and achievement of normal or improved adult height.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15492975

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN： 1548-5595            Impact factor:   3.620


  2 in total

1.  The association between abnormal birth history and growth in children with CKD.

Authors:  Larry A Greenbaum; Alvaro Muñoz; Michael F Schneider; Frederick J Kaskel; David J Askenazi; Randall Jenkins; Hilary Hotchkiss; Marva Moxey-Mims; Susan L Furth; Bradley A Warady
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Slipped capital femoral epiphysis and its association with endocrine, metabolic and chronic diseases: a systematic review of the literature.

Authors:  M Witbreuk; F J van Kemenade; J A van der Sluijs; E P Jansma; J Rotteveel; B J van Royen
Journal:  J Child Orthop       Date:  2013-03-30       Impact factor: 1.548
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.